Skip to main content
LobbyMap

Alexion Pharmaceuticals

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
51/100
Moderate Influence
$6.7M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
1
Revolving Door

Alexion Pharmaceuticals reported $6.7 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of the Treasury
Dept of Housing & Urban Development
Food & Drug Administration
U.S. Senate
Dept of Agriculture
U.S. House of Representatives
White House Office

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecCapitol Counsel
GOVMEDPHA
1$290K
2024 Jul-SepHogan Lovells
PHAMEDGOV
1$254K
2024 Apr-JunCovington & Burling
GOVPHAHCR+1
2$247K
2024 Jan-MarFierce Government Relations
HCRMED
1$270K
2023 Oct-DecPeck Madigan Jones
GOVHCR
4$372K
2023 Jul-SepS-3 Group
HCRPHAMED
4$396K
2023 Apr-JunAkin Gump Strauss Hauer & Feld
HCRGOVMED
4$331K
2023 Jan-MarCassidy & Associates
GOVHCR
4$439K

Alexion Pharmaceuticals Lobbying FAQ

Alexion Pharmaceuticals has spent $6.7M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Alexion Pharmaceuticals lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Alexion Pharmaceuticals has an Influence Score of 51/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Alexion Pharmaceuticals employs 4 registered lobbyists, of whom 1 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Alexion Pharmaceuticals has contacted 7 government entities as part of their lobbying activities, including Dept of the Treasury, Dept of Housing & Urban Development, Food & Drug Administration.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.